Login to Your Account



Financings Roundup

Satori Raises $15M for AD Platform, Looks to File IND

By Marie Powers
Staff Writer

Friday, February 24, 2012
Privately held Satori Pharmaceuticals Inc. raised $15 million in an inside round from existing investors as it prepares to move its Alzheimer's disease (AD) technology into the clinic.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription